Penicillamine and C-reactive protein abnormal - a phase IV clinical study of FDA data

Summary:

C-reactive protein abnormal is reported as a side effect among people who take Penicillamine (penicillamine), especially for people who are female, 30-39 old, also take Orencia, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have C-reactive protein abnormal when taking Penicillamine. It is created by eHealthMe based on reports of 1,329 people who have side effects when taking Penicillamine from the FDA, and is updated regularly.

What is Penicillamine?

Penicillamine has active ingredients of penicillamine. eHealthMe is studying from 1,329 Penicillamine users. Check the latest studies of Penicillamine.

What is C-reactive protein abnormal?

C-reactive protein abnormal is found to be associated with 412 drugs and 280 conditions by eHealthMe. Check the latest studies of C-reactive protein abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

1,329 people reported to have side effects when taking Penicillamine.
Among them, 34 people (2.56%) have C-reactive protein abnormal.

Could Penicillamine cause C-reactive protein abnormal?

Among these 34 people:

What is the gender of people who have C-reactive protein abnormal when taking Penicillamine? *

female: 100 %
male: 0.0 %

What is the age of people who have C-reactive protein abnormal when taking Penicillamine? *

What are other drugs people take besides Penicillamine? *

What are other side effects people have besides C-reactive protein abnormal? *

Joint Pain: 34 people, 100.00%
Sle Arthritis (an autoimmune disease that causes your immune system to attack your body's own joints): 34 people, 100.00%
Red Blood Cell Sedimentation Rate Abnormal: 34 people, 100.00%
Pain In Jaw: 34 people, 100.00%
Pain In Extremity: 34 people, 100.00%
Overlap Syndrome (an autoimmune disease of connective tissue): 34 people, 100.00%
Neck Pain: 34 people, 100.00%
Nausea (feeling of having an urge to vomit): 34 people, 100.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 34 people, 100.00%
Joint Swelling: 34 people, 100.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 34 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Penicillamine and have C-reactive protein abnormal?

- Check whether C-reactive protein abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Penicillamine:

Penicillamine (1,329 reports)

Browse all side effects of Penicillamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with C-reactive protein abnormal:

C-reactive protein abnormal (412 drugs)

Browse all the conditions that are associated with C-reactive protein abnormal:

C-reactive protein abnormal (280 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on penicillamine (the active ingredients of Penicillamine) and Penicillamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.